Biosyent investor
WebAug 23, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be … WebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr.
Biosyent investor
Did you know?
WebMar 24, 2024 · Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product ... WebShares of BioSyent are available in the United States on the OTC Pink Marketplace under the trading symbol BIOYF. 2. Looking for general information about your shares? All …
WebNov 17, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that … WebNov 15, 2012 · TORONTO, ONTARIO--(Marketwire - Nov 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results. - Q3 2012 Sales of $1,575,598 sets an all time quarterly record and grew by 60% over Q3 2011
WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of a bust so far, with the stock ... WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It …
WebNov 16, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that …
WebMar 9, 2024 · Investor Takeaway. BioSyent appears to be fairly valued. The company is expected to report Q4 earnings on March 21, 2024, and it will be important to see the percentage growth of FeraMAX sales in ... dundee cycling routesWebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then … dundee dentistry ucat cut offWebJun 11, 2024 · A copy of the early warning report will be available under BioSyent’s profile on SEDAR at www.sedar.com, or may be obtained by contacting Ryan Caughey, General Counsel and Corporate Secretary at ... dundee daily newspaperWebApr 6, 2024 · BioSyent's mailing address is 170 Attwell Dr Suite 520, ETOBICOKE, ON M9W 5Z5, Canada. The official website for the company is www.biosyent.com. The … dundee cycle hireWebBioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … dundee daily paperWebFeb 1, 2024 · Article content. MISSISSAUGA, Ontario, Feb. 01, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on March 15, 2024, to shareholders of record at the close of … dundee dickow white pine miWebMar 21, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be … dundee days out with the kids